DANIEL ERNESTO
CASTELLANO GAUNA
Profesor asociado de Ciencias de la Salud
Brigham and Women's Hospital
Boston, Estados UnidosPublications en collaboration avec des chercheurs de Brigham and Women's Hospital (5)
2022
-
First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial
European Urology, Vol. 81, Núm. 3, pp. 266-271
2018
-
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 [Figure presented]
European Urology
-
Nivolumab plus Ipilimumab versus Sunitinib in advanced renal-cell carcinoma
New England Journal of Medicine, Vol. 378, Núm. 14, pp. 1277-1290
-
The clinical activity of PD-1/PD-L1 inhibitors in metastatic non–clear cell renal cell carcinoma
Cancer Immunology Research, Vol. 6, Núm. 7, pp. 758-765
2015
-
Nivolumab versus everolimus in advanced renal-cell carcinoma
New England Journal of Medicine, Vol. 373, Núm. 19, pp. 1803-1813